Leave Your Message
Akụkọ

Akụkọ

Otu akụkọ
Akụkọ egosipụtara
akwadoro ọrụ
ngwa ngwa njikọ
Akụkọ kacha ọhụrụ: IL-4 na-eme ka ike ọgwụgwụ nke mkpụrụ ndụ CD8+ CART

Akụkọ kacha ọhụrụ: IL-4 na-eme ka ike ọgwụgwụ nke mkpụrụ ndụ CD8+ CART

2025-01-16
Na Septemba 12, 2024, Carli M. Stewart na ndị ọrụ ibe bipụtara otu akụkọ dị mkpa na Nature Communications, na-akọwapụta ọrụ Interleukin-4 (IL-na-eme ka ike ọgwụgwụ nke mkpụrụ ndụ CD8+ CAR T, akụkụ dị oke egwu nke ọgwụgwọ cell CAR T. Ọmụmụ ahụ na-emesi mmetụta nke IL-4 na ọgwụgwọ ọrịa cancer T. Nchoputa a nwere ike ime ka atumatu di nma iji kwalite oru sel CAR T na ibelata ike ọgwụgwụ, na-eme ka ihe omuma nke di nma nke oma nwere ike ime ka ulo oru dika Alpha Lifetech Incorporation, nke na-agbasi mbọ ike n'ịkwalite usoro immunotherapy.
lee nkọwa
Akụkọ| Mgbakwunye-n'ịkọwa mkpokọta mpaghara nwere ike ịkpata adịghị arụ ọrụ cell CAR-T

Akụkọ| Mgbakwunye-n'ịkọwa mkpokọta mpaghara nwere ike ịkpata adịghị arụ ọrụ cell CAR-T

2025-01-09
Nnyocha e bipụtara n'oge na-adịbeghị anya na Nature Communications na August 13, 2023, na-ekpughe na ntinye aka na-ekpebi mpaghara (CDR) n'ime otu akụkụ agbanwe agbanwe (scFv) nwere ike ịkpata nchịkọta CAR, na-eduga na isi okwu na chimeric antigen receptor (CAR) -T cell therapy. Ndị nchọpụta chọpụtara na nchịkọta a na-akpata ọdịda cell CAR-T, ọnwụ cell, na mbelata mmeghachi omume tumor cell na antigens ezubere iche. Nke a na-ebute ọrụ antigen na-adabere na ya yana nrụrụ arụ ọrụ nke mkpụrụ ndụ CAR-T. Mmetụta nke nyocha a na-egosipụta ihe ịma aka dị oke mkpa n'ịkwalite ịdị irè nke usoro ọgwụgwọ CAR-T, ihe na-elekwasị anya na nyocha na-aga n'ihu n'ọhịa, karịsịa maka ụlọ ọrụ dị ka Alpha Lifetech Incorporation, bụ nke a raara nye ịkwalite nkà na ụzụ CAR.
lee nkọwa
Usoro Sanger vs. Usoro ọgbọ na-abịa (NGS)

Usoro Sanger vs. Usoro ọgbọ na-abịa (NGS)

2024-11-27

Alpha Lifetech Incorporation na-agbanwegharị ngalaba nke teknụzụ biotechnology site na ịnye ọrụ mgbago elu na mgbada ala ahaziri maka protein ndị na-emegharị ahụ. Site n'ilekwasị anya n'iwepụta akụrụngwa protein dị elu, Alpha Lifetech bu n'obi ịhazi nyocha na usoro mmepe maka ụlọ ọrụ biopharmaceutical. Site n'inye ihe ngwọta ọhụrụ nke na-egbo mkpa ụlọ ọrụ ahụ kpọmkwem, ụlọ ọrụ ahụ na-ahụ maka mmepụta nke ọma na ịdị ọcha nke protein. Ebumnuche a na-akwalite ikike nke ndị ọkà mmụta sayensị na ndị nyocha na ọkwa Alpha Lifetech dị ka onye ndu na ngalaba biotechnology. Site na ntinye aka n'ịkwalite teknụzụ protein, Alpha Lifetech Incorporation dị njikere inye aka dị ukwuu na ọganihu sayensị na mmepe ọgwụgwọ.

lee nkọwa
Ntuziaka zuru oke maka ihicha protein: Ụzọ, usoro, na ngwa

Ntuziaka zuru oke maka ihicha protein: Ụzọ, usoro, na ngwa

2024-10-30

Alpha Lifetech Incorporation ekwupụtala nyocha zuru oke nke ịdị ọcha protein, nzọụkwụ dị mkpa na usoro mmepụta protein. Ntụleghachi ahụ na-enye nghọta ndị bụ isi na isi ihe dị mkpa maka nyocha na nyocha na-esote na ngalaba nke ịdị ọcha protein. A na-atụ anya na nlebanya a ga-enye aka dị ukwuu n'ọganihu nke mmepụta protein na mmepe nke ebumnuche ọgwụgwọ ọhụrụ. A maara Alpha Lifetech Incorporation maka nka ya n'ichepụta biopharmaceutical ma na-agba mbọ ịnye ihe ngwọta dị mma maka ịdị ọcha protein. A na-atụ anya nyocha a ka ọ nwee mmetụta dị ukwuu na ụlọ ọrụ ahụ ma mee ka ọnọdụ Alpha Lifetech sie ike dị ka onye ndu na nyocha na mmepe biopharmaceutical.

lee nkọwa
Akụkọ kacha ọhụrụ| Nnyocha ọhụrụ na-egosi na ọ nwere ike igbanwe mbibi ọrịa kansa

Akụkọ kacha ọhụrụ| Nnyocha ọhụrụ na-egosi na ọ nwere ike igbanwe mbibi ọrịa kansa

2024-09-27

Na June 1, 2024, na akwụkwọ akụkọ Nature Communications, ndị ọkà mmụta sayensị sitere na ndị otu nyocha Bo Li bipụtara otu isiokwu akpọrọ "Area postrema neurons mediate interleukin-6 function in cancer cachexia". Akụkọ ahụ chọpụtara na mmụba nke interleukin-6 nwere ike ibute arụ ọrụ ụbụrụ yana n'ikpeazụ cachexia cancer.

lee nkọwa
Akụkọ kacha ọhụrụ | Onye mmechi nke mbụ n'ime klas nke EGFR na PI3K na-enye ụzọ otu-molecule maka ịchedo nguzogide mmegide.

Akụkọ kacha ọhụrụ | Onye mmechi nke mbụ n'ime klas nke EGFR na PI3K na-enye ụzọ otu-molecule maka ịchedo nguzogide mmegide.

2024-09-11

Na July 11, 2024, otu ndị nchọpụta nke Dr. Judith Sebolt Leopold na-eduzi haziri kinase inhibitor MTX-531 nke nwere ike igbochi epidermal growth factor receptor (EGFR) na phosphatidylinositol 3-OH kinase (PI3K).

lee nkọwa
Jiri ọgwụ mgbochi biosimilar mee ka nchọpụta ọgwụ mee ngwa ngwa - Ngwa ngwa ngwa ijikọ ejikọta

Jiri ọgwụ mgbochi biosimilar mee ka nchọpụta ọgwụ mee ngwa ngwa - Ngwa ngwa ngwa ijikọ ejikọta

2024-04-30

Alfa Lifetech's 700+ biosimilar antibodies lekwasịrị anya EGFR, TNF-α, VEGF, na-eme ka nyocha ọgwụ na-eme ngwa ngwa n'ịdị mma akwadoro.

lee nkọwa
Imeghe ihe omimi nke usoro ndu: Alpha Lifetech na-ewepụta protein protein dị elu maka ndị sayensị.

Imeghe ihe omimi nke usoro ndu: Alpha Lifetech na-ewepụta protein protein dị elu maka ndị sayensị.

2024-04-30

Alpha Lifetech na-enye protein akpụkpọ anụ dị mma maka nchọpụta ọgwụ yana nghọta cellular, na-eji usoro mmepụta dị elu.

lee nkọwa
Nkà na Sayensị nke Nchọpụta Nanobody: ka Alpha Lifetech si na-akwagide ókèala

Nkà na Sayensị nke Nchọpụta Nanobody: ka Alpha Lifetech si na-akwagide ókèala

2024-04-29

Chọpụta teknụzụ nanobody: ngosipụta phage, ọgwụ mgbochi, nyocha, nhọrọ, na nyocha nhazi na Alpha Lifetech maka nyocha na ọgwụgwọ.

lee nkọwa